 (BrJ Ophthalmol 1994; 78: 244-248) 
For more detailed information on the immunoscintigraphic procedure we refer to a previous publication.7 The interpretation of the scans was made by a nuclear physician who was unaware of the localisation of the tumour. A scintigraphic result was given as positive, negative, or doubtful. A doubtful result is defined as a trace of activity on one side which cannot be judged as positive. Measurements with a double pinhole collimator were carried out to quantify the radioactivity and to achieve an increase in detection rate.7 The measurements were performed immediately after the whole body scans 6 hours after injection. The ratios ofthe counts ofthe left and the right eye at 6 hours post injection were calculated. Variance analysis was used to determine the significance of differences in counts between both eyes.
During the course of this study it was decided to perform single photon emission computed tomography (SPET) in case of a negative or doubtful result with planar scintigraphy. SPET gives a reconstructed image which may help to detect tumours not visualised with planar scintigraphy. SPET aquisition was carried out at 6 hours after administration. The same gammacamera and collimator were used as for the planar images. The patient was placed in a supine position and 60 views of 30 seconds were taken over a 360°rotation in a 128x 128 matrix. Horizontal slices were reconstructed by means of filtered back projection using a Shepp and Logan filter. Subsequently, coronal slices were calculated. In all cases the slice thickness was 2 pixels -that is, 5 4 mm. SPET is useful to visualise nasally localised tumours which may be obscured by a specific background activity in the nasopharynx region.89 Therefore a possible corelation between tumour location and detectability with SPET was investigated. Results of SPET were given according to the same criteria as planar scintigraphy.
The melanomas were divided according to their localisation in the eye. The following localisations were used: (1) posterior pole and peripapillary area, (2) temporal periphery, (3) nasal periphery, (4) peripheral 6 immunoscintigraphy such as an increase of the tumour/background ratio by means of a three step labelling procedure used in cutaneous melanoma and other tumours'6 or the use of a diester linkage between chelate and antibody. '7 Latest results of the Collaborative Ocular Melanoma Study in the United States show false positive results in only 0-5% of melanoma patients" indicating that the diagnosis of choroidal melanoma in a clinical centre with regular diagnostic modalities is accurate. At present the main limitation of scintigraphy in choroidal melanoma is the limited tumour size although a computed reconstruction programme for SPET reconstruction may increase the detection rate of immunoscintigraphy. Since small tumours present most difficulties in diagnosis, immunoscintigraphy is at present not a valuable diagnostic technique for small choroidal lesions.
